TG Therapeutics Inc (TGTX)
Net profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 12,672 | -198,335 | -348,101 | -279,381 | -172,870 |
Revenue | US$ in thousands | 221,047 | 2,785 | 6,689 | 152 | 152 |
Net profit margin | 5.73% | -7,121.54% | -5,204.08% | -183,803.29% | -113,730.26% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $12,672K ÷ $221,047K
= 5.73%
TG Therapeutics Inc's net profit margin has shown significant fluctuations over the past five years. In particular, the company experienced extremely negative net profit margins in 2020 and 2019, indicating substantial losses relative to its revenue during those years. However, there was a notable improvement in profitability in 2021 and 2022, where the net profit margins were negative but not as severely as in the previous years. In 2023, the company achieved a positive net profit margin of 5.73%, signifying a profit relative to its total revenue for that year. Overall, the trend in net profit margin shows variability in the company's ability to generate profits, with the most recent year displaying a more favorable financial performance compared to the preceding years.
Peer comparison
Dec 31, 2023